Frontlight ResearchEarly access
Trial site
North Estonia Medical Centre
- 7running trials
- 5closed trials
The trials here
What the 12 trials at this site are about, from their registry records.
- Conditions
- Coronary artery disease4 trials
- Multiple myeloma2 trials
- Atopic dermatitis (eczema)1 trial
- Colorectal cancer1 trial
- Gastric and oesophageal cancer1 trial
- High blood pressure1 trial
- Lung cancer1 trial
- Phase
- Phase 24 trials
- Phase 31 trial
- Status
- Completed5 trials
- Active, not recruiting3 trials
- Recruiting3 trials
- Enrolling by invitation1 trial
- Lead sponsor
- Aarhus University Hospital Skejby2 trials
- Amgen2 trials
- North Estonia Medical Centre2 trials
- Diagram B.V.1 trial
- European Organisation for Research and Treatment of Cancer - EORTC1 trial
- and 4 more
Running trials
Enrolling by invitation
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Durvalumab(MEDI4736) After chemoRadioTherapy(DART) for NSCLC-a Translational and Biomarker Study
Recruiting
ISCHEMIA-CTO Trial - Revascularisation or Optimal Medical Therapy of CTO
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Coronary artery disease2 recruiting
- Colorectal cancer1 recruiting
- Multiple myeloma1 recruiting
Closed trials
Completed
Completed
Completed
Completed
Study of Early Relapsed, Lenalidomide-refractory Subjects Eligible for Carfilzomib Triplet
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026